Combined hormonal contraception and the risk of venous thromboembolism: a guideline

Fertil Steril. 2017 Jan;107(1):43-51. doi: 10.1016/j.fertnstert.2016.09.027. Epub 2016 Oct 25.

Abstract

While venous thromboembolism (VTE) is rare in young women of reproductive age, combined oral contraceptives increase the risk of VTE. In the patient in whom combined hormonal contraception is appropriate, it is reasonable to use any currently available preparation.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Age Factors
  • Blood Coagulation / drug effects*
  • Contraceptives, Oral, Combined / administration & dosage*
  • Contraceptives, Oral, Combined / adverse effects
  • Contraceptives, Oral, Hormonal / administration & dosage
  • Contraceptives, Oral, Hormonal / adverse effects*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Obesity / complications
  • Patient Selection
  • Pulmonary Embolism / blood
  • Pulmonary Embolism / chemically induced*
  • Pulmonary Embolism / diagnosis
  • Pulmonary Embolism / prevention & control
  • Risk Assessment
  • Risk Factors
  • Smoking / adverse effects
  • Thrombophilia / blood
  • Thrombophilia / complications
  • Venous Thromboembolism / blood
  • Venous Thromboembolism / chemically induced*
  • Venous Thromboembolism / diagnosis
  • Venous Thromboembolism / prevention & control
  • Venous Thrombosis / blood
  • Venous Thrombosis / chemically induced*
  • Venous Thrombosis / diagnosis
  • Venous Thrombosis / prevention & control

Substances

  • Contraceptives, Oral, Combined
  • Contraceptives, Oral, Hormonal

Supplementary concepts

  • Thrombophilia, hereditary